日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units - A high risk community-hospital interface

肾透析中心SARS-CoV-2传播的遗传流行病学——高风险的社区-医院界面

Li, Kathy K; Woo, Y Mun; Stirrup, Oliver; Hughes, Joseph; Ho, Antonia; Filipe, Ana Da Silva; Johnson, Natasha; Smollett, Katherine; Mair, Daniel; Carmichael, Stephen; Tong, Lily; Nichols, Jenna; Aranday-Cortes, Elihu; Brunker, Kirstyn; Parr, Yasmin A; Nomikou, Kyriaki; McDonald, Sarah E; Niebel, Marc; Asamaphan, Patawee; Sreenu, Vattipally B; Robertson, David L; Taggart, Aislynn; Jesudason, Natasha; Shah, Rajiv; Shepherd, James; Singer, Josh; Taylor, Alison H M; Cousland, Zoe; Price, Jonathan; Lees, Jennifer S; Jones, Timothy P W; Lopez, Carlos Varon; MacLean, Alasdair; Starinskij, Igor; Gunson, Rory; Morris, Scott T W; Thomson, Peter C; Geddes, Colin C; Traynor, Jamie P; Breuer, Judith; Thomson, Emma C; Mark, Patrick B

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis

盐皮质激素受体拮抗剂对蛋白尿和慢性肾脏病进展的影响:系统评价和荟萃分析

Currie, Gemma; Taylor, Alison H M; Fujita, Toshiro; Ohtsu, Hiroshi; Lindhardt, Morten; Rossing, Peter; Boesby, Lene; Edwards, Nicola C; Ferro, Charles J; Townend, Jonathan N; van den Meiracker, Anton H; Saklayen, Mohammad G; Oveisi, Sonia; Jardine, Alan G; Delles, Christian; Preiss, David J; Mark, Patrick B

Inter-study reproducibility of arterial spin labelling magnetic resonance imaging for measurement of renal perfusion in healthy volunteers at 3 Tesla

在3特斯拉磁场下,动脉自旋标记磁共振成像测量健康志愿者肾脏灌注的跨研究重复性

Gillis, Keith A; McComb, Christie; Foster, John E; Taylor, Alison H M; Patel, Rajan K; Morris, Scott T W; Jardine, Alan G; Schneider, Markus P; Roditi, Giles H; Delles, Christian; Mark, Patrick B

AA amyloidosis in a patient with Langerhans cell histiocytosis

患有朗格汉斯细胞组织细胞增生症的患者的AA型淀粉样变性

Thomson, Peter C; Taylor, Alison H M; Morris, Scott T W; Kipgen, David; Mactier, Robert A

Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer

醋酸阿比特龙对CYP17的选择性抑制作用在治疗去势抵抗性前列腺癌方面具有很高的活性。

Attard, Gerhardt; Reid, Alison H M; A'Hern, Roger; Parker, Christopher; Oommen, Nikhil Babu; Folkerd, Elizabeth; Messiou, Christina; Molife, L Rhoda; Maier, Gal; Thompson, Emilda; Olmos, David; Sinha, Rajesh; Lee, Gloria; Dowsett, Mitch; Kaye, Stan B; Dearnaley, David; Kheoh, Thian; Molina, Arturo; de Bono, Johann S